Current Evidence for IL-17/23 Blockade for the Treatment of Lupus Nephritis

In the current medical literature, there is increasing evidence for the involvement of the interleukin (IL)-17/23 axis and the potential role of Th17 cells in the pathogenesis of lupus nephritis. Knowledge about the interaction of these immunological pathways in the development of autoimmune disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Santacruz, Juan Camilo, Pulido, Sandra, Arzuaga, Angelo, Mantilla, Marta Juliana, Santos, Ana María, Londono, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720001/
https://www.ncbi.nlm.nih.gov/pubmed/34993035
http://dx.doi.org/10.7759/cureus.20087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720001/
https://www.ncbi.nlm.nih.gov/pubmed/34993035
http://dx.doi.org/10.7759/cureus.20087

Ejemplares similares